Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Slipicevic

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Hemasphere|March 4, 2022
The Peptide-Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell DeathKen Flanagan, Romika Kumari, Juho J Miettinen, et al.
Scientific Reports|July 13, 2017
Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cellsXiaoran Li, Jie Lu, Quancheng Kan, et al.
Signal Transduction and Targeted Therapy|June 10, 2026
Targeting NFATc1-regulated MTHFD2 one-carbon metabolism to suppress sustained T-cell-mediated inflammation in rheumatoid arthritisTheodora Manolakou, Jianyu Shen, Sanjaykumar Boddul, et al.
Cancers|April 3, 2021
Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to MelflufenJuho J Miettinen, Romika Kumari, Gunnhildur Asta Traustadottir, et al.
Experimental Hematology & Oncology|December 24, 2025
Efficacy of melflufen in multiple myeloma with mutated or deleted TP53Klara Acs, Juho J Miettinen, Philipp Sergeev, et al.
Pigment Cell & Melanoma Research|November 20, 2014
Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cellsMarie R Webster, Mai Xu, Kathryn A Kinzler, et al.
Nature Metabolism|April 3, 2023
Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cellsAlanna C Green, Petra Marttila, Nicole Kiweler, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Hemasphere|March 4, 2022
The Peptide-Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell DeathKen Flanagan, Romika Kumari, Juho J Miettinen, et al.
Scientific Reports|July 13, 2017
Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cellsXiaoran Li, Jie Lu, Quancheng Kan, et al.
Signal Transduction and Targeted Therapy|June 10, 2026
Targeting NFATc1-regulated MTHFD2 one-carbon metabolism to suppress sustained T-cell-mediated inflammation in rheumatoid arthritisTheodora Manolakou, Jianyu Shen, Sanjaykumar Boddul, et al.
Cancers|April 3, 2021
Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to MelflufenJuho J Miettinen, Romika Kumari, Gunnhildur Asta Traustadottir, et al.
Experimental Hematology & Oncology|December 24, 2025
Efficacy of melflufen in multiple myeloma with mutated or deleted TP53Klara Acs, Juho J Miettinen, Philipp Sergeev, et al.
Pigment Cell & Melanoma Research|November 20, 2014
Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cellsMarie R Webster, Mai Xu, Kathryn A Kinzler, et al.
Nature Metabolism|April 3, 2023
Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cellsAlanna C Green, Petra Marttila, Nicole Kiweler, et al.
Pageof 4